Why do oestrogen levels drop

Overview

Estrogen is a crucial female sex hormone produced primarily in the ovaries, with smaller amounts from adrenal glands and fat tissue. Historically, understanding of estrogen dates to the 1920s when scientists first isolated the hormone, leading to the development of hormone replacement therapy in the 1940s. Estrogen levels naturally fluctuate throughout a woman's life, peaking during reproductive years and declining with age. The most significant drop occurs during menopause, defined as 12 consecutive months without menstruation, which marks the end of reproductive capability. Beyond reproduction, estrogen affects over 400 bodily functions including bone density maintenance, cardiovascular health, skin elasticity, and brain function. The decline in estrogen has been studied extensively since the 1970s, with the Women's Health Initiative study in 2002 providing important data on hormone therapy risks and benefits.

How It Works

Estrogen levels drop through several biological mechanisms. During perimenopause, the transitional phase before menopause, ovarian follicles become less responsive to follicle-stimulating hormone (FSH), leading to irregular ovulation and declining estrogen production. The ovaries gradually produce less estradiol, the most potent form of estrogen, while continuing to produce some androstenedione that converts to estrone in fat tissue. This shift results in a changing estrogen ratio with more estrone relative to estradiol. In surgical menopause from oophorectomy, estrogen production ceases immediately as the primary source is removed. In conditions like premature ovarian insufficiency, autoimmune attacks or genetic factors cause ovarian dysfunction before age 40. Medications like aromatase inhibitors block estrogen synthesis by inhibiting the aromatase enzyme that converts androgens to estrogen. Lifestyle factors including extreme exercise, low body fat, and chronic stress can also suppress estrogen production through hypothalamic-pituitary-ovarian axis disruption.

Why It Matters

Understanding estrogen decline is crucial because it impacts millions of women's health and quality of life. The drop in estrogen contributes to menopausal symptoms affecting approximately 75% of women, including hot flashes, night sweats, vaginal dryness, and mood changes. Long-term consequences include increased risk of osteoporosis, with postmenopausal women losing up to 20% of bone density in the first 5-7 years after menopause. Cardiovascular risk rises as estrogen's protective effects on blood vessels diminish. The economic impact is significant, with menopause-related productivity losses estimated at billions annually. Hormone therapy, developed to address these effects, must be carefully managed due to varying individual risks. Research continues on timing hypothesis suggesting early intervention may provide cardiovascular benefits while minimizing risks. Understanding estrogen decline also informs treatments for conditions like breast cancer where estrogen suppression is therapeutic.